LIMK1 and fragile X syndrome: These novel LIMK inhibitors significantlydecrease p-cofilin in Fmr1 KO mice and in stem cell-derivedcortical neurons from FXS patients, thereby 85 representsa superior tool compound in vitro and in vivo to explore LIMK biologyin addition to potential treatment of LIMK pathologies such as FXS.